Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE:500124

₹6370.25 16.55 (0.26%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

6284.20

Today’s High

6381.00

52W low

5076.20

52W High

6505.90

Open Price

6345.00

Prev. Close

5890.9500

Volume

375058.00

Value

2389213224.50

Fundamentals

Market Cap Cr

106274.70

Price to Earnings

19.10

Price to Book Value

3.80

Dividend Yield

0.60

PE to Growth

0.80

Op Revenue TTM Cr

28011.10

Net Profit TTM Cr

5577.90

Cash From Operating Activity Cr

4543.30

Return on Equity %

19.74

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

6294.7

10Day EMA

6205.2

12Day EMA

6180.1

20Day EMA

6114.4

26Day EMA

6088.3

50Day EMA

6057.2

100Day EMA

6019.4

200Day EMA

5842.9

5Day SMA

6286.4

10Day SMA

6150.4

20Day SMA

6069.4

30Day SMA

6003.1

50Day SMA

6022.8

100Day SMA

6130

150Day SMA

6002.3

200Day SMA

5880.2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 Jul, 2024

54.7

Week

54.4

Month

58.4

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

6345.15

PIVOT

First Resistance

6406.05

Second Resistance

6441.85

Third Resistance

6502.75

First Support

6309.35

Second Support

6248.45

Third Support

6212.65

Relative Strength Index

68.34

Money Flow Index

67.68

MACD

91.81

MACD Signal

48.27

Average True Range

127.23

Average Directional Index

17.07

Rate of Change (21)

9.99

Rate of Change (125)

9.87

Commodity Channel Index

170.4

Williams %R

-18.5

BETA

1 Month

0.24

3 Month

0.4

1 Year

0.36

3 Year

0.03

PRICE CHANGE ANALYSIS

↑ 4.8%

1 Week

Low

High

5995

6480

↑ 9.99%

1 Month

Low

High

5600

6480

↑ 2.13%

3 Months

Low

High

5600

6480

↑ 7.48%

6 Months

Low

High

5520.65

6505.9

↑ 23.46%

1 Year

Low

High

5076.25

6505.9

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 5317.50 4330.60 5061.80 5670.90 4668.80 3949.00 4998.30 4034.00 3783.40 3542.60 3941.50
Operating Expenses Qtr 3700.20 3446.70 3209.60 3209.60 3488.80 3221.50 3077.50 3051.10 2989.00 2865.60 3075.10
Operating Profit Qtr 1378.60 656.30 1629.10 2227.70 1061.10 675.10 1802.80 579.50 669.90 614.00 748.30
EBIDT Qtr Cr 1591.30 883.90 1852.20 2461.30 1175.90 726.50 1920.80 982.90 784.60 677.00 866.40
Depreciation Qtr 246.20 246.40 245.80 237.20 236.70 238.80 226.20 221.50 205.20 205.40 206.60
Net Profit Qtr 1034.80 475.20 1192.60 1639.40 672.40 324.60 1116.30 499.50 419.70 341.10 449.00
Basic EPS Qtr 62.14 28.55 71.68 98.66 40.49 19.54 67.25 30.10 25.29 20.55 27.07
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 20346.10 17553.80 14887.20 14150.20 12593.60
Operating Expenses Annual Cr 13557.40 12747.70 11811.10 10212.30 8980.80
Operating Profit Annual 5926.40 4214.80 2594.10 3136.80 2869.60
Operating Profit Margin Annual % 29.13 24.01 17.43 22.17 22.79
Total Expenses Annual Cr 14554.80 13687.80 12663.40 11094.00 9817.80
EBIDT Annual Cr 6788.70 4806.10 3076.10 3937.90 3612.80
EBIDT Annual margin % 33.37 27.38 20.66 27.83 28.69
Depreciation 975.60 923.20 814.30 835.00 789.20
PAT Before ExtraOrdinary Items Annual Cr 4342.00 2612.80 1623.20 2186.40 2937.70
Net Profit Annual 4342.00 2612.80 1623.20 2186.40 2937.70
Basic EPS Annual 260.95 157.37 97.85 131.84 177.23
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 24240.80 20474.20 18336.20 16983.70 15191.90
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 580.40 460.90 114.30 85.60 103.40
Total Current Liabilities Annual Cr 5538.10 4439.70 6045.10 4560.30 4180.50
Total Capital Plus Liabilities Annual Cr 30359.30 25374.80 24495.60 21629.60 19475.80
Fixed Assets Annual 8800.10 8119.70 7350.80 6745.10 4845.70
Total Non Current Assets Annual 12543.40 11586.50 11012.00 10685.40 9369.10
Total Current Assets Annual 17815.90 13788.30 13483.60 10944.20 10106.70
Total Assets Annual 30359.30 25374.80 24495.60 21629.60 19475.80
Contingent Liabilities plus Commitments Annual Cr - 830.20 827.40 1062.80 1068.60
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 3449.70 5052.90 1338.70 3514.20 1839.20
Cash from Investing Activity Annual -3430.30 -3447.60 -2038.00 -1458.00 -1689.20
Cash from Financing Annual Activity 68.10 -2696.90 505.50 -794.30 -224.10
Net Cash Flow Annual - -1091.60 -193.80 1261.90 -74.10
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 1453.29 1228.94 1101.93 1020.65 914.07
ROE Annual % 17.91 12.76 8.85 12.87 19.33
ROCE Annual % 23.41 18.54 12.25 18.17 18.46
Total Debt to Total Equity Annual 0.03 0.00 0.12 0.07 0.07
EBDIT Annual Margin % 34.84 28.33 21.35 29.49 30.48
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 7311.30 7453.00 7217.60 6931.90 6453.70 6848.50 6372.60 6086.80 5596.80 5394.10 5992.40
Operating Expenses Qtr 5299.90 5213.70 4888.80 4694.70 4727.30 4837.90 4430.40 4291.70 4282.00 4117.90 4427.10
Operating Profit Qtr 1831.20 2023.10 2008.30 2062.10 1533.90 1938.50 1898.90 941.20 451.00 1215.70 1359.80
EBIDT Qtr Cr 2028.70 2239.30 2323.30 2236.10 1672.40 1997.20 1939.70 1795.10 572.90 1271.50 1565.30
Depreciation Qtr 367.70 373.50 375.50 353.30 315.50 323.70 309.20 301.80 293.00 294.20 294.10
Net Profit Qtr 1309.80 1380.90 1482.20 1405.00 960.10 1243.90 1114.20 1189.00 97.00 709.30 995.80
Basic EPS Qtr 78.66 82.94 89.09 84.55 57.79 74.91 67.13 71.64 5.84 42.75 60.03
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 28905.40 25725.20 22029.60 19338.90 18137.60
Operating Expenses Annual Cr 20078.00 18320.70 17777.50 15177.60 15046.60
Operating Profit Annual 7933.10 6349.00 3767.70 3869.90 2470.40
Operating Profit Margin Annual % 27.45 24.68 17.10 20.01 13.62
Total Expenses Annual Cr 21719.10 19713.70 19038.50 16503.40 16308.00
EBIDT Annual Cr 8827.40 7404.50 4252.10 4161.30 3091.00
EBIDT Annual margin % 30.54 28.78 19.30 21.52 17.04
Depreciation 1470.00 1250.20 1165.20 1228.80 1163.10
PAT Before ExtraOrdinary Items Annual Cr 5563.20 4470.30 2112.20 1903.60 1969.90
Net Profit Annual 5577.90 4507.30 2182.50 1951.60 2026.00
Basic EPS Annual 334.59 270.90 131.21 117.34 121.99
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 28254.80 23286.10 19212.40 17641.70 15598.80
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 1021.00 426.90 768.70 871.30 412.40
Total Current Liabilities Annual Cr 9588.00 8572.10 9765.80 8103.80 7214.10
Total Capital Plus Liabilities Annual Cr 38863.80 32285.10 29746.90 26616.80 23225.30
Fixed Assets Annual 11294.80 9701.80 8867.60 9210.90 7894.10
Total Non Current Assets Annual 14058.50 11859.60 11964.60 12066.50 10626.20
Total Current Assets Annual 24805.30 20425.50 17782.30 14550.30 12599.10
Total Assets Annual 38863.80 32285.10 29746.90 26616.80 23225.30
Contingent Liabilities plus Commitments Annual Cr - 929.80 936.80 1077.40 1040.60
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 4543.30 5887.50 2810.80 3570.30 2984.10
Cash from Investing Activity Annual -4028.30 -4137.30 -2638.70 -2266.00 -492.30
Cash from Financing Annual Activity -376.30 -2686.10 -242.20 -29.80 -2515.90
Net Cash Flow Annual - -935.90 -70.10 1274.50 -24.10
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 1693.93 1397.72 1154.59 1060.20 938.56
ROE Annual % 19.74 19.35 11.35 11.06 12.98
ROCE Annual % 25.13 25.95 15.44 15.84 12.04
Total Debt to Total Equity Annual 0.06 0.05 0.16 0.15 0.11
EBDIT Annual Margin % 31.51 30.01 19.73 21.84 17.64
Name Holding Percent Holding Id Pledged % Locked %
HDFC TRUSTEE COMPANY LTD. A/C HDFC NIFTY 50 ETF 1.62 75054981 - -
NPS TRUST-A/C SBI PENSION FUND SCHEME TAX SAVER-TIER 2 2.3 75054986 - -
GOVERNMENT OF SINGAPORE 1.02 75054993 - -
Name Holding Percent Holding Id Pledged % Locked %
KALLAM SATISH REDDY HUF 3.31 75054964 0 0
GUNUPATI VENKATESWARA PRASAD HUF 1.52 75054965 0 0
SAMRAJYAM REDDY KALLAM 0.67 75054966 0 0
SATISH REDDY KALLAM 0.54 75054967 0 0
APS Trust 20.59 75054977 0 0
Name Holding Percent Holding Id
HDFC TRUSTEE COMPANY LTD. A/C HDFC NIFTY 50 ETF 1.62 75054981
SBI-ETF NIFTY 50 1.42 75054982
FIRST SENTIER INVESTORS ICVC - STEWART INVESTORS ASIA PACIFIC LEADERS SUSTAINABILITY FUND 2.32 75054992
GOVERNMENT OF SINGAPORE 1.02 75054993
LIFE INSURANCE CORPORATION OF INDIA P & GS FUND 5.05 75054984
J P Morgan Chase Bank NA 15.35 75054989
NPS TRUST-A/C SBI PENSION FUND SCHEME TAX SAVER-TIER 2 2.3 75054986
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Jul 11, 2023 40 FINAL - Equity Share
Jul 11, 2022 30 FINAL - Equity Share
Jul 09, 2021 25 FINAL - Equity Share
Jul 13, 2020 25 FINAL - Equity Share
Jul 15, 2019 20 FINAL - Equity Share
Jul 16, 2018 20 FINAL - Equity Share
Jul 17, 2017 20 FINAL - Equity Share
Jul 18, 2016 20 FINAL - Equity Share
Jul 10, 2015 20 FINAL - Equity Share
Jul 11, 2014 18 FINAL - Equity Share
Jul 12, 2013 15 FINAL - Equity Share
Jun 28, 2012 13.75 FINAL - Equity Share
Jun 30, 2011 11.25 FINAL - Equity Share
Jul 02, 2010 11.25 FINAL - Equity Share
Jul 03, 2009 6.25 FINAL - Equity Share
Jul 04, 2008 3.75 FINAL - Equity Share
Jul 06, 2007 3.75 FINAL - Equity Share
Jul 07, 2006 5 FINAL - Equity Share
Jul 07, 2005 5 FINAL - Equity Share
Jul 13, 2004 5 FINAL - Equity Share
Aug 08, 2003 5 FINAL - Equity Share
Aug 08, 2002 - FINAL - Equity Share
Nov 08, 2001 - INTERIM Nov 26, 2001 Equity Share
Jun 18, 2001 - FINAL - Equity Share
Sep 07, 2000 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Oct 10, 2001 10:5 2001-10-25
Ex-Date Purpose Notes
May 07, 2024 Audited Results & Final Dividend -
Jan 30, 2024 Quarterly Results -
Oct 27, 2023 Quarterly Results -
Jul 26, 2023 Quarterly Results -
May 10, 2023 Audited Results & Final Dividend -
Jan 25, 2023 Quarterly Results -
Oct 28, 2022 Quarterly Results -
Jul 28, 2022 Quarterly Results -
May 19, 2022 Audited Results & Final Dividend -
Jan 28, 2022 Quarterly Results -
Oct 29, 2021 Quarterly Results -
Jul 27, 2021 Quarterly Results -
May 14, 2021 Audited Results & Final Dividend -
Jan 29, 2021 Quarterly Results -
Oct 28, 2020 Quarterly Results -
Jul 29, 2020 Quarterly Results -
May 20, 2020 Audited Results & Final Dividend (Revised)
May 13, 2020 Audited Results & Final Dividend -
Mar 27, 2020 Others Inter alia, to consider and approve Raising of funds through issuance of Commercial Papers.
Jan 27, 2020 Quarterly Results -
Nov 01, 2019 Quarterly Results -
Jul 29, 2019 Quarterly Results -
May 17, 2019 Audited Results & Final Dividend -
Feb 01, 2019 Quarterly Results -
Oct 26, 2018 Quarterly Results -
Jul 26, 2018 Quarterly Results -
May 22, 2018 Audited Results & Dividend -
Jan 25, 2018 Quarterly Results -
Oct 31, 2017 Quarterly Results -
Jul 27, 2017 Quarterly Results -
May 12, 2017 Audited Results & Dividend -
Feb 04, 2017 Quarterly Results -
Oct 25, 2016 Quarterly Results -
Jul 26, 2016 Quarterly Results -
May 12, 2016 Audited Results & Dividend -
Feb 17, 2016 Buy Back of Shares -
Feb 09, 2016 Quarterly Results -
Oct 29, 2015 Quarterly Results -
Jul 30, 2015 Quarterly Results -
May 12, 2015 Audited Results & Final Dividend -
Jan 29, 2015 Quarterly Results -
Oct 29, 2014 Quarterly Results -
Jul 30, 2014 Quarterly Results -
May 13, 2014 Audited Results & Dividend -
Feb 11, 2014 Quarterly Results -
Oct 31, 2013 Quarterly Results -
Jul 30, 2013 Quarterly Results -
May 14, 2013 Audited Results & Dividend -
Feb 14, 2013 Quarterly Results -
Oct 30, 2012 Quarterly Results -
Jul 19, 2012 Quarterly Results -
May 11, 2012 Audited Results & Dividend -
Feb 03, 2012 Quarterly Results -
Oct 25, 2011 Quarterly Results -
Jul 20, 2011 Quarterly Results -
May 13, 2011 Audited Results & Dividend -
Jan 25, 2011 Quarterly Results -
Oct 23, 2010 Quarterly Results -
Jul 22, 2010 Quarterly Results -
May 06, 2010 Audited Results, Dividend & ESOP To grant of 16,800 stock options, exercisable at par value of Rs. 5/- to the Independent Directors of the Co. under "Dr. Reddy's ESOS, 2002" & "Dr. Reddy's Employees ADR Stock Option Scheme, 2007".
Mar 31, 2010 Issuance of Bonus Debentures For issuance of bonus debentures to Shareholders of the Co. from its General Reserves built from undistributed profits, The allotment of debentures will account for an amount not exceeding Rs. 520 Cr.
Jan 20, 2010 Quarterly Results -
Oct 23, 2009 Quarterly Results -
Jul 21, 2009 Quarterly Results -
May 18, 2009 Audited Results, Dividend & Others To grant of 9,000 stock options, exercisable at par value of Rs 5/- to the Independent Directors of the Co. under "Dr. Reddy's ESOS 2002" & "Dr. Reddy's Employees ADR Stock Option Scheme, 2007".
Jan 20, 2009 Quarterly Results -
Oct 23, 2008 Quarterly Results & Amalgamation To consider a Scheme of Amalgamation in terms of which Periecan Pharma Pvt. Ltd, a wholly owned subsidiary of the Company will be amalgamated with Dr. Reddy's Laboratories Ltd.
Jul 21, 2008 Quarterly Results -
May 20, 2008 Audited Results & Dividend -
Jan 25, 2008 Quarterly Results -
Oct 24, 2007 Quarterly Results -
Jul 23, 2007 Quarterly Results -
May 18, 2007 Audited Results & Dividend -
Jan 22, 2007 Quarterly Results -
Oct 27, 2006 Quarterly Results -
Jul 27, 2006 Quarterly Results -
May 31, 2006 Accounts & Dividend -
Jan 24, 2006 Quarterly Results -
Oct 29, 2005 Quarterly Results -
Jul 26, 2005 Quarterly Results -
May 06, 2005 Accounts & Dividend -
Jan 31, 2005 Quarterly Results -
Oct 26, 2004 Quarterly Results -
Jul 27, 2004 Quarterly Results -
Jan 30, 2004 Quarterly Results -
Oct 28, 2003 Quarterly Results -
Jul 31, 2003 Quarterly Results -
May 30, 2003 Accounts & Dividend -
Jan 28, 2003 Quarterly Results -
Oct 24, 2002 Quarterly Results -
Jul 31, 2002 Quarterly Results -
Jun 04, 2002 Accounts & Dividend -
Mar 04, 2002 Interim Dividend -
Jan 29, 2002 Quarterly Results -
Oct 31, 2001 Quarterly, H.Y. Results & I. Dividend -
Jul 31, 2001 Quarterly Results & Others Stock Split & Employees Stock Option Plan
May 30, 2001 Accounts & Dividend -
Jan 30, 2001 Quarterly Results -
Oct 30, 2000 Quarterly Results -
Jul 28, 2000 Quarterly Results -
Mar 23, 2000 Interim Dividend and Issue of ADS -
Mar 06, 2000 Merger -
Oct 20, 1999 Quarterly Results -
Jul 29, 1999 Quarterly Results -
Apr 19, 1999 Accounts & Dividend -
Jan 30, 1999 Quarterly Results -
Oct 21, 1998 Quarterly Results -
Apr 27, 1998 Accounts & Dividend -
May 17, 1997 Accounts & Dividend. -
Ex-Date Bonus Ratio Record Date
Aug 28, 2006 1:1 2006-08-29
Bigul
02 Jul 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Transcript Of Investor Call

 Transcript of Investor call
Bigul
02 Jul 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Reg. 34 (1) Annual Report.

 Integrated Annual Report FY2024
Bigul
02 Jul 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Business Responsibility and Sustainability Reporting (BRSR)

 BRSR for FY2024
Bigul
02 Jul 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Notice Of 40Th AGM And Integrated Annual Report FY2024

 Notice of 40th AGM and Integrated Annual Report FY2024
Bigul
02 Jul 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Bigul
28 Jun 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Press Release
28 Jun 2024

Dr. Reddy's - To Acquire Global OTC Portfolio For Ex-U.S. Market: HDFC Securities

 The closing of the transaction is subject to satisfactory completion of customary conditions, including regulatory approvals, and it is expected to close in early Q4 CY24.
Bigul
27 Jun 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Audio recordings of the Investor call
Bigul
26 Jun 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Analyst Call
Bigul
26 Jun 2024

DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Acquisition

 Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
See all News

FAQs

The latest market price of Dr. Reddy's Laboratories Ltd. on NSE was Rs. 6370.25 as of today.

The opening share price of Dr. Reddy's Laboratories Ltd. was Rs. 6345.00 as of today.

The 52-week high share price of Dr. Reddy's Laboratories Ltd. was Rs. 6505.90.

The 52 week low share price of Dr. Reddy's Laboratories Ltd. was Rs. 5076.20.

Dr. Reddy's Laboratories Ltd. has a market cap of Rs. 106274.70 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Dr. Reddy's Laboratories Ltd. is 0.80. Please refer to the Fundamentals section for further details.

The operating revenue for Dr. Reddy's Laboratories Ltd. in the last FY was Rs.  28011.10 crore. Please refer to the Financials section for further details.

The Net Profit for Dr. Reddy's Laboratories Ltd. in the last FY was Rs. 5577.90 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Dr. Reddy's Laboratories Ltd. was on 2023-07-11 for Rs. 40 per share. According to today’s share price, the dividend yield of Dr. Reddy's Laboratories Ltd. stands at 0.60. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Dr. Reddy's Laboratories Ltd. was as of 2006-08-28. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Dr. Reddy's Laboratories Ltd. was as of 2001-10-10. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Dr. Reddy's Laboratories Ltd..

Close

Let's Open Free Demat Account